| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 05/03/2000 | EP0996735A2 Chimeric vectors comprising a phage packaging site and a portion derived from the genome of a eukaryotic virus |
| 05/03/2000 | EP0996731A2 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses |
| 05/03/2000 | EP0559884B1 Viral recombinant vectors for expression in muscle cells |
| 05/03/2000 | CN1252075A Synthetic HIV GAG genes |
| 05/02/2000 | US6057300 Introducing expression vector comprising gene encoding p21 and expression vector comprising second gene encoding immunotherapeutic agent, genetic therapeutic, cytokine or prodrug converting enzyme to treat restenosis |
| 05/02/2000 | US6057158 Mammalian cell line having a recombinant plasmid with inverted terminal repeats, packaging sequences, and gene of interest and a helper adenovirus having loxp sequences and packaging sequences; for improved gene therapy |
| 05/02/2000 | US6057152 Recombinant viral vector system |
| 05/02/2000 | US6057143 Recombinant enzymatically active calpain expressed in a baculovirus system |
| 04/27/2000 | WO2000023955A1 Virus-like particles for the induction of autoantibodies |
| 04/27/2000 | WO2000023574A2 Hepatitis a vaccines |
| 04/27/2000 | WO2000023465A2 Methods and reagents for isolating biologically active peptides |
| 04/27/2000 | WO2000023103A1 Viral mastitis |
| 04/27/2000 | CA2346500A1 Methods and reagents for isolating biologically active peptides |
| 04/26/2000 | EP0994959A1 Polymer-modified viruses |
| 04/26/2000 | EP0994949A1 Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences |
| 04/26/2000 | EP0994724A1 Methods and compositions for impairing multiplication of hiv-1 |
| 04/25/2000 | US6054565 Nucleic Acids of HIV-2, Diagnostic Test Kit and Method using Nucleic Acid Probes of HIV-2 |
| 04/25/2000 | US6054312 Receptor-mediated gene delivery using bacteriophage vectors |
| 04/25/2000 | US6054283 Antibodies against human herpesvirus-6(HHV-6) and method of use |
| 04/25/2000 | US6054131 Vaccine composition for herpes simplex virus and method of using |
| 04/25/2000 | CA2019803C Feline interferon and process for production thereof |
| 04/20/2000 | WO2000022152A1 Compositions and methods for producing recombinant adeno-associated virus |
| 04/20/2000 | WO2000022137A2 Selectively replicating viral vectors |
| 04/20/2000 | WO2000022136A2 Recombinant e1a deleted adenoviral vectors |
| 04/20/2000 | WO2000005347A3 Hepatitis b culture system |
| 04/20/2000 | CA2345900A1 Selectively replicating viral vectors |
| 04/20/2000 | CA2345211A1 Recombinant e1a deleted adenoviral vectors |
| 04/18/2000 | US6051427 Retroviral packaging plasmid including retroviral helper dna lacking native enhancer and/or promoter of the viral 5' long terminal repeat, the psi function sequence and the 3' long terminal repeat, but encodes foreign regulatory sequences |
| 04/18/2000 | US6051410 Self-assembled, defective, nonself-propagating viral particles |
| 04/18/2000 | US6051404 A nucleic acid encoding a protein; vaccines for poultry |
| 04/18/2000 | CA2092195C Retroviral packaging cell line |
| 04/13/2000 | WO2000020574A2 Fusions of scaffold proteins with random peptide libraries |
| 04/13/2000 | WO2000020573A2 Dna shuffling to produce nucleic acids for mycotoxin detoxification |
| 04/13/2000 | WO2000020565A1 Enhanced immunogen for inactivated vaccine for infection with japanese encephalitis viruses and process for producing the same |
| 04/13/2000 | WO2000020433A1 Cytotoxic agents for the selective killing of lymphoma and leukemia cells and methods of use thereof |
| 04/13/2000 | WO2000020041A2 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent |
| 04/13/2000 | WO1999060110A3 Stable envelope proteins for retroviral, viral and liposome vectors and use in gene and drug therapy |
| 04/13/2000 | WO1999055345A9 Combination viral-based and gene-based therapy of tumors |
| 04/13/2000 | CA2345408A1 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent |
| 04/13/2000 | CA2345215A1 Fusions of scaffold proteins with random peptide libraries |
| 04/13/2000 | CA2345203A1 Dna shuffling to produce nucleic acids for mycotoxin detoxification |
| 04/12/2000 | EP0991771A2 Lentivirus based vector and vector system |
| 04/12/2000 | CN1250480A Eukaryotic gene expression cassette and uses thereof |
| 04/11/2000 | US6048686 Hyperthermia and immunotherapy for cancer |
| 04/11/2000 | US6048685 In vitro diagnostic assay employing HIV-2 antigens for the detection of HIV-2 specific antibodies |
| 04/11/2000 | US6048537 Concentration, purification, fragmentation, deactivation |
| 04/06/2000 | WO2000018969A1 Methods to selectively inactivate viruses in biological compositions |
| 04/06/2000 | WO2000018906A2 Shuffling of codon altered genes |
| 04/06/2000 | WO2000018240A1 Gene delivery system and methods of use |
| 04/06/2000 | WO2000001835A3 Targeted integration into chromosomes using retroviral vectors |
| 04/06/2000 | WO1999055132A3 Generation of packaging system for human recombinant adenoviral vectors |
| 04/06/2000 | CA2345230A1 Methods to selectively inactivate viruses in biological compositions |
| 04/06/2000 | CA2331335A1 Shuffling of codon altered genes |
| 04/05/2000 | EP0990041A1 Regulation of transcription in mammalian cells and viral replication by a tetracyclin repressor |
| 04/05/2000 | EP0989999A1 Antitumoral composition based on immunogenic polypeptide with modified cell location |
| 04/05/2000 | EP0989992A1 $i(RUPESTRIS) STEM PITTING ASSOCIATED VIRUS NUCLEIC ACIDS, PROTEINS, AND THEIR USES |
| 04/05/2000 | EP0989863A2 System for the in vivo delivery and expression of heterologous genes in the bone marrow |
| 04/05/2000 | EP0989860A1 Methods and compositions for inactivating infectious agents using lactoferrin and related molecules |
| 04/04/2000 | US6046175 Procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis |
| 04/04/2000 | US6045803 Administering to an avian a recombinant herpesvirus of turkeys for expressing an antigenic polypeptide to treat viral diseases |
| 04/04/2000 | US6045802 Antitumor agents treating cancer |
| 04/04/2000 | US6045790 A cell culture product from an equine influenza virus and the human influenza virus a/puerto rico/ 8/34, comprises rna encoding for at least one neuraminidase or haemagglutinin surface antigen and matrix protein |
| 03/30/2000 | WO2000017377A2 Methods for large-scale production of recombinant aav vectors |
| 03/30/2000 | WO2000017374A1 Retroviral particles protected against complement mediated destruction |
| 03/30/2000 | WO2000017373A1 Recombinant celo virus and celo virus dna |
| 03/30/2000 | WO2000017371A1 Polynucleotide constructs and uses thereof |
| 03/30/2000 | WO2000017361A2 Interferon-epsilon |
| 03/30/2000 | WO1999061601A9 Aav5 vector and uses thereof |
| 03/30/2000 | CA2347129A1 Methods for large-scale production of recombinant aav vectors |
| 03/30/2000 | CA2343324A1 Polynucleotide constructs and uses thereof |
| 03/30/2000 | CA2343090A1 Retroviral particles protected against complement mediated destruction |
| 03/30/2000 | CA2342773A1 Interferon-epsilon |
| 03/30/2000 | CA2339866A1 Recombinant celo virus and celo virus dna |
| 03/29/2000 | EP0988390A1 Alternatively targeted adenovirus |
| 03/29/2000 | EP0988389A1 Method for the production of non-group c adenoviral vectors |
| 03/29/2000 | EP0988376A2 Noey2 gene compositions and methods of use |
| 03/29/2000 | CN1248627A Construction and use of plasmid type Herpes simplex virus series carrier |
| 03/29/2000 | CN1248471A Vero cell encephalitis B inactivated vaccine and preparation process thereof |
| 03/28/2000 | US6043077 Directed aganist specific nucleotide sequences to inhibit replication, infectivity, or gene expression of the virus; for prevention or viricides with side effect reduction |
| 03/28/2000 | US6042843 Baculovirus for the control of insect pests |
| 03/28/2000 | US6042835 Prototype FelV isolates for use in disease models and vaccines |
| 03/28/2000 | US6042830 Viral agent associated with mystery swine disease |
| 03/23/2000 | WO2000015853A1 Recombinant newcastle disease virus rna expression systems and vaccines |
| 03/23/2000 | WO2000015823A1 Alternatively targeted adenovirus |
| 03/23/2000 | WO2000015820A1 Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
| 03/23/2000 | WO2000015792A2 Promotion or inhibition of angiogenesis and cardiovascularization |
| 03/23/2000 | CA2342396A1 Alternatively targeted adenovirus |
| 03/22/2000 | EP0986649A1 Retroviral vector particles produced in a baculovirus expression system |
| 03/21/2000 | US6040174 Defective adenoviruses and corresponding complementation lines |
| 03/21/2000 | US6040170 Human cytomegalovirus DNA sequences |
| 03/21/2000 | US6040169 Variant strain incapable of replicating in central nervous system neurons but able to elicit a good immunological and cell mediated response |
| 03/21/2000 | CA1340931C Infectious bural disease virus |
| 03/16/2000 | WO2000014240A2 Attenuated salmonella sp12 mutants as antigen carriers |
| 03/16/2000 | WO2000014220A1 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus |
| 03/16/2000 | WO2000014205A2 Methods for generating high titer helper-free preparations of released recombinant aav vectors |
| 03/16/2000 | WO2000003029A3 Chimaeric adenoviruses |
| 03/16/2000 | WO2000000628B1 Replication-defective recombinant adenovirus with mutated major late promoter |
| 03/16/2000 | WO2000000216A3 Use of poxviruses as enhancer of specific immunity |
| 03/16/2000 | WO1999060131A3 Hemorrhagic enteritis virus dna sequences, proteins encoded thereby and various uses thereof |
| 03/16/2000 | CA2342849A1 Methods for generating high titer helper-free preparations of released recombinant aav vectors |